Cytotoxicity of dopamine-derived tetrahydroisoquinolines on melanoma cells

Biochemical Pharmacology

Volumn 64, Issue 10, 2002, Pages 1503-1512

  De Marco, Federico ^a   Perluigi, Marzia ^b   Marcante, Maria Luisa ^a   Coccia, Raffaella ^b   Foppoli, Cesira ^b   Blarzino, Carla ^b   Rosei, Maria Anna ^b  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Cytotoxicity; Melanoma cells; Quinones; ROS; Tetrahydroisoquinolines

Indexed keywords

ACETYLCYSTEINE; ANTIOXIDANT; CATALASE; CATECHOL; DIHYDROLIPOAMIDE DEHYDROGENASE; DOPAMINE; ENZYME; MELANIN; MONOPHENOL MONOOXYGENASE; OXOGLUTARATE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE; SALSOLINOL; SUPEROXIDE DISMUTASE; TETRAHYDROISOQUINOLINE DERIVATIVE; TETRAHYDROPAPAVEROLINE;

AMELANOTIC MELANOMA; ANIMAL CELL; ARTICLE; CELL DEATH; CELL LINE; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; DRUG RESPONSE; DRUG TOLERANCE; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME SUBSTRATE; HUMAN; HUMAN CELL; MELANOMA CELL; MELANOSIS; METABOLISM; MOUSE; NONHUMAN; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTECTION; UPREGULATION;

ANTIOXIDANTS; CELL SURVIVAL; DOPAMINE; DRUG INTERACTIONS; HUMANS; ISOQUINOLINES; KETOGLUTARATE DEHYDROGENASE COMPLEX; MELANOMA; MONOPHENOL MONOOXYGENASE; NEUROTOXINS; RNA, MESSENGER; TETRAHYDROISOQUINOLINES; TUMOR CELLS, CULTURED;

EID: 0037112143     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(02)01353-9     Document Type: Article

References (69)

1. Dietrich R., Erwin V. Biogenic amine-aldehyde condensation products: tetrahydropapaverolines and tryptolines. Ann. Rev. Pharmacol. Toxicol. 20:1980;55-80.
2. Musshoff F., Daldrup T., Bonte W., Leitner A., Lesch O.M. Salsolinol and norsalsolinol in human urine samples. Pharmacol. Biochem. Behav. 58:1997;545-550.
3. Niwa T., Takeda N., Kaneda N., Hashizume Y., Nagatsu T. Presence of tetrahydroisoquinoline and 2-methyl tetrahydroisoquinoline in Parkinsonian and human brains. Biochem. Biophys. Res. Commun. 144:1987;1084-1089.
4. Collins A.C., Cashaw J.L., Davis V.E. Dopamine derived tetrahydroisoquinolines alkaloids inhibitors of neuroamine metabolism. Biochem. Pharmacol. 22:1973;2337-2348.
5. Minami M., Takahashi T., Maruyama W., Takahashi A., Dostert P., Nagatsu T., Naoi M. Inhibition of tyrosine hydroxylase by R and S enantiomers of salsolinol, 1-methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline. J. Neurochem. 58:1992;2097-2101.
6. Minami M., Maruyama W., Dostert P., Nagata T., Naoi M. Inhibition of type A and B monoamine oxidase by 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinolines and their N-methylated derivatives. J. Neural. Transm. Gen. Sect. 92:1993;125-135.
7. Giovine A., Renis M., Bertolino A. In vivo and in vitro studies on the effect of tetrahydropapaveroline and salsolinol on COMT and MAO activity in rat brain. Pharmacology. 14:1976;86-94.
8. Cohen G., Katz S. 6,7-Dihydroxytetrahydroisoquinoline: evidence for in vivo inhibition of intraneuronal monoamine oxidase. J. Neurochem. 25:1975;719-722.
9. Thull U., Kneubuhler S., Gaillard P., Carrupt P.A., Testa B., Altomare C., Carotti A., Jenner P., McNaught K.S. Inhibition of monoamine oxidase by isoquinoline derivatives. Qualitative and 3D-quantitative structure-activity relationships. Biochem. Pharmacol. 50:1995;869-877.
10. Rosei M.A., Mosca L. Production of melanin pigments by chemical and enzymatic oxidation of tetrahydroisoquinolines. Biochem. Mol. Biol. Int. 35:1995;1253-1259.
11. Rosei M.A., Foppoli C., Wang X.T., Coccia R., Mateescu M.A. Production of melanins by ceruloplasmin. Pigment Cell Res. 11:1998;98-102.
12. Mosca L., Blarzino C., Coccia R., Foppoli C., Rosei M.A. Melanins from tetrahydroisoquinolines. Spectroscopic characteristics, scavenging activity and redox transfer properties. Free Radic. Biol. Med. 24:1998;161-167.
13. Rosei M.A. Opiomelanins synthesis and properties. Histol. Histopathol. 16:2001;931-935.
14. Napolitano A., Palumbo A., Misuraca G., Prota G. Inhibitory effect of melanin precursors on arachidonic acid peroxidation. Biochim. Biophys. Acta. 1168:1993;175-180.
15. Riley PA. New approaches to the utilization of the melanogenic, pathway as a targeting strategy in antimelanoma therapy. In: Hori Y, Hearing VJ, Nakayama J, editors. Melanogenesis and malignant melanoma: biochemistry, cell biology, molecular biology, pathophysiology, diagnosis and treatment. Amsterdam: Elsevier, 1996. p. 271-5.
16. Wick M.M., Byers L., Frei E. L-Dopa: selective toxicity for melanoma cells in vitro. Science. 197:1977;468-469.
17. Urabe K., Aroca P., Tsukamoto K., Mascagna D., Palumbo A., Prota G., Hearing V. The inherent cytotoxicity of melanin precursors: a revision. Biochim. Biophys. Acta. 1221:1994;272-278.
18. Ito S., Inoue S., Fujita K. The mechanism of toxicity of 5-S-cysteinyldopa to tumour cells. Hydrogen peroxide as a mediator of cytotoxicity. Biochem. Pharmacol. 32:1983;2079-2081.
19. Pawelek J.M., Lerner A.B. 5,6-Dihydroxyindole is a melanin precursor showing a potent cytotoxicity. Nature. 276:1978;627-628.
20. Prota G. Melanins and melanogenesis. San Diego: Harcourt Brace Jovanovich Publishers/Academic Press, Inc., 1992.
21. Wardman P. Bioreductive activation of quinones: redox properties and thiol reactivity. Free Radic. Res. Commun. 8:1990;219-229.
22. Graham D.G. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol. Pharmacol. 14:1978;633-643.
23. Montine T.J., Picklo M.J., Amarnath V., Whetsell W.O. Jr., Graham D.G. Neurotoxicity of endogenous cysteinylcatechols. Exp. Neurol. 148:1997;26-33.
24. Kappus H., Sies H. Toxic drug effects associated with oxygen metabolism: redox cycling and lipid peroxidation. Experientia. 37:1981;1233-1241.
25. Karg E., Rosengren E., Rorsman H. Hydrogen peroxide as a mediator of dopac-induced effects on melanoma cells. J. Invest. Dermatol. 96:1991;224-227.
26. Passi S., Picardo M., Nazzaro-Porro M. Comparative cytotoxicity of phenols in vitro. Biochem. J. 245:1987;537-542.
27. De Marco F., Di Lonardo A., Venuti A., Marcante M.L. Interferon inhibition of neoplastic phenotype in cell lines harbouring human papillomavirus sequences. J. Biol. Regul. Homeost. Agents. 5:1991;65-70.
28. Gerlier D., Thomasset N. Use of MTT colorimetric assay to measure cell activation. J. Immunol. Methods. 94:1986;5763-5769.
29. Ernster L. DT-Diaphorase. In: Eastbrook RW, Pullman ME, editors. Methods in enzymology, vol. 10. New York: Academic Press, 1967. p. 309-17.
30. Park L.C., Zhang H., Sheu K.F., Calingasan N.Y., Kristal B.S., Lindsay J.G., Gibson G.E. Metabolic impairment induces oxidative stress, compromises inflammatory responses, and inactivates a key mitochondrial enzyme in microglia. J. Neurochem. 72:1999;1948-1958.
31. Pekovich S.R., Martin P.R., Singleton C.K. Thiamine deficiency decreases steady-state transketolase and piruvate dehydrogenase but not α-ketoglutarate dehydrogenase mRNA levels in three human cell types. J. Nutr. 128:1998;683-687.
32. Jara J.R., Solano F., Lozano A.L. Assays for mammalian tyrosinase: a comparative study. Pigment Cell Res. 1:1988;332-339.
33. Winder A.J., Harris H. New assays for the tyrosine hydroxylase and dopa oxidase activities of tyrosinase. Eur. J. Biochem. 198:1991;317-326.
34. +-ATPase inhibitors in amelanotic, tyrosinase positive human and mouse melanoma cells. FEBS Lett. 478:2000;57-60.
35. Calogero A., Timmer-Bosscha H., Schrafford Koops H., Tiebosch A.T., Mulder N.H., Hospers G.A. Limitations of the nested reverse transcriptase polymerase chain reaction on tyrosinase for the detection of malignant melanoma micrometastases in lymph nodes. Br. J. Cancer. 83:2000;184-187.
36. Tsukamoto K., Hirata S., Osada A., Kitamura R., Shimada S. Detection of circulating melanoma cells by RT-PCR amplification of three different melanocyte-specific mRNAs in a mouse model. Pigment Cell Res. 13:2000;185-189.
37. Dondi E., Pattyn E., Lutfalla G., Van Ostade X., Uze G., Pellegrini S., Tavernier J. Down-modulation of type 1 interferon responses by receptor cross-competition for a shared JAK kinase. J. Biol. Chem. 276:2001;47004-47012.
38. Ernster L. DT-Diaphorase: its structure, function, regulation and its role in antioxidant defence and cancer chemotherapy. In: Yagi K, editor. Pathophysiology of lipid peroxides and related free radicals. Tokyo, Japan: Sc Sco Press, 1967. p. 1-24.
39. Smit N.P., Hoogduijn M.J., Riley P.A., Pavel S. Study of DT-diaphorase in pigment-producing cells. Cell Mol. Biol. 45:1999;1041-1046.
40. Burdon R.H. Superoxide and hydrogen peroxide in relation to mammalian cell proliferation. Free Radic. Biol. Med. 18:1995;775-794.
41. Maruyama W., Dostert P., Matsubara K., Naoi M. N-Methyl salsolinol produces hydroxyl radicals: involvement to neurotoxicity. Free Radic. Biol. Med. 19:1995;67-75.
42. Maruyama W., Dostert P., Naoi M. Dopamine-derived 1-methyl-6,7-dihydroxyisoquinolines as hydroxyl radical promoters and scavengers in rat brain: in vivo and in vitro studies. J. Neurochem. 64:1995;2635-2643.
43. Nappi A.J., Vass E., Collins M.A. Contrasting effects of catecholic and O-methylated tetrahydroisoquinolines on hydroxyl radical production. Biochim. Biophys. Acta. 1434:1999;64-73.
44. Basma A.N., Morris E.J., Nicklas W.J., Geller H.M. L-Dopa cytotoxicity to PC12 cells in culture is via its autoxidation. J. Neurochem. 64:1995;825-832.
45. Nappi A.J., Vass E. Comparative studies of enhanced iron-mediated production of hydroxyl radical by glutathione, cysteine, ascorbic acid, and selected catechols. Biochim. Biophys. Acta. 1336:1997;295-302.
46. Jung Y., Surh Y. Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free Radic. Biol. Med. 30:2001;1407-1417.
47. Karg E., Tunek A., Brotell H., Rosengren E., Rorsman H. Alteration of glutathione level in human melanoma cells: effect of N-acetyl-L-cysteine and its analogues. Pigment Cell Res. 3:1990;11-15.
48. Zhang F., Dryhurst G. Effects of L-cysteine on the oxidation chemistry of dopamine: new reaction pathways of potential relevance to idiopathic Parkinson's disease. J. Med. Chem. 37:1994;1084-1098.
49. van Muiswinkel F.L., Riemers F.M., Peters G.J., LaFleur M.V., Siegel D., Jongenelen C.A., Drukarch B. L-Dopa stimulates expression of the antioxidant enzyme NAD(P)H:quinone oxidoreductase (NQO) in cultured astroglial cells. Free Radic. Biol. Med. 29:2000;442-453.
50. Slominski A., Moellmann G., Kuklinska E., Bomirski A., Pawelek J. Positive regulation of melanin pigmentation by two key substrates of the melanogenic pathway, L-tyrosine and L-dopa. J. Cell Sci. 89:1988;287-296.
51. Naeyaert J.M., Eller M., Gordon P.R., Park H.Y., Gilchrest B.A. Pigment content of cultured human melanocytes does not correlate with tyrosinase message level. Br. J. Dermatol. 125:1991;297-303.
52. Fuller B.B., Drake M.A., Spaulding D.T., Chaudhry F. Downregulation of tyrosinase activity in human melanocyte cell cultures by yohimbine. J. Invest. Dermatol. 114:2000;268-276.
53. Wood J.M., Schallreuter K.U. Studies on the reactions between human tyrosinase, superoxide anion, hydrogen peroxide and thiols. Biochim. Biophys. Acta. 1074:1991;378-385.
54. Valverde P., Manning P., Todd C., McNeil C.J., Thody A.J. Tyrosinase may protect human melanocytes from the cytotoxic effects of the superoxide anion. Exp. Dermatol. 5:1996;247-253.
55. Valverde P., Manning P., McNeil C.J., Thody A.J. Activation of tyrosinase reduces the cytotoxic effects of the superoxide anion in B16 mouse melanoma cells. Pigment Cell Res. 9:1996;77-84.
56. McNaught K.S., Altomare C., Cellamare S., Carotti A., Thull U., Carrupt P.A., Testa B., Jenner P., Marsden C.D. Inhibition of alpha-ketoglutarate dehydrogenase by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine (MPTP). Neuroreport. 6:1995;1105-1108.
57. Pardo B., Mena M.A., de Yebenes J.G. L-Dopa inhibits complex IV of the electron transport chain in catecholamine-rich human neuroblastoma NB69 cells. J. Neurochem. 64:1995;576-582.
58. Offen D., Ziv I., Panet H., Wasserman L., Stein R., Melamed E., Barzilai A. Dopamine-induced apoptosis is inhibited in PC12 cells expressing Bcl-2. Cell. Mol. Neurobiol. 17:1997;289-304.
59. Storch A., Kaftan A., Burkhardt K., Schwarz J. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 855:2000;67-75.
60. Nagatsu T. Isoquinoline neurotoxins in the brain and Parkinson's disease. Neurosci. Res. 29:1997;99-111.
61. Collins M.A., Bidgeli M.G. Biosynthesis of tetrahydroisoquinoline alkaloids in brain and other tissues of ethanol-intoxicated rats. Adv. Exp. Med. Biol. 59:1975;79-91.
62. Dostert P., Strolin Benedetti M., Dordain G. Dopamine-derived alkaloids in alcoholism and in Parkinson's and Huntington's diseases. J. Neural. Transm. 74:1988;61-74.
63. McNaught K.S., Carrupt P.A., Altomare C., Cellamare S., Carotti A., Testa B., Jenner P., Marsden C.D. Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56:1998;921-933.
64. Sjoquist B., Eriksson A., Winblad B. Salsolinol and catecholamines in human brain and their relation to alcoholism. Prog. Clin. Biol. Res. 90:1982;57-67.
65. Maruyama W., Sango K., Iwasa K., Minami C., Dostert P., Kawai M., Moriyasu M., Naoi M. Dopaminergic neurotoxins 6,7-dihydroxy-1-(3′,4′-dihydroxybenzyl)-isoquinolines, cause different types of cell death in SH-SY5Y cells: apoptosis was induced by oxidized papaverolines and necrosis by reduced tetrahydropapaverolines. Neurosci. Lett. 291:2000;89-92.
66. Melamed E., Offen D., Shirvan A., Djaldetti R., Barzilai A., Ziv I. Levodopa toxicity and apoptosis. Ann. Neurol. 44:1998;S149-S154.
67. Migheli R., Godani C., Sciola L., Delogu M.R., Serra P.A., Zangani D., De Natale G., Miele E., Desole M.S. Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: role of oxidative stress. J. Neurochem. 73:1999;1155-1163.
68. Lenaz G. Role of mitochondria in oxidative stress ad ageing. Biochim. Biophys. Acta. 1366:1998;53-67.
69. Dypbukt J.M., Ankarcrona M., Burkitt M., Sjoholm A., Strom K., Orrenius S., Nicotera P. Different prooxidant levels stimulate growth, trigger apoptosis, or produce necrosis of insulin-secreting RINm5F cells. The role of intracellular polyamines. J. Biol. Chem. 269:1994;30553-30560.